Atossa Therapeutics, Inc.
ATOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26 | -$30 | -$27 | -$21 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $5 | $7 | $5 |
| Change in WC | $0 | $2 | -$1 | -$1 |
| Other Non-Cash | $2 | $3 | $0 | $0 |
| Operating Cash Flow | -$21 | -$21 | -$21 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$5 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$5 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $0 | $0 | $70 |
| Stock Repurch. | $0 | -$1 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $44 |
| Financing Cash Flow | $4 | -$1 | $0 | $113 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17 | -$22 | -$25 | $97 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $89 | $111 | $136 | $40 |
| End Cash | $71 | $89 | $111 | $136 |
| Free Cash Flow | -$21 | -$21 | -$21 | -$16 |